Prognostic Indicators and Outcomes following Surgical Management of Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck

Metastatic cutaneous SCC carries a poor prognosis with 5-year survival of 25-57%. The aim of this study is to examine the outcomes following surgery with adjuvant therapy for management of metastatic cSCC in a UK based population.

Source: The British Journal of Oral and Maxillofacial Surgery - January 15, 2021 Category: ENT & OMF Authors: J.E. O ’Connell, A. Saeed, H.B. Jones, C.J. Lloyd Source Type: research